Details for New Drug Application (NDA): 091646
✉ Email this page to a colleague
The generic ingredient in GLATIRAMER ACETATE is glatiramer acetate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the glatiramer acetate profile page.
Summary for 091646
Tradename: | GLATIRAMER ACETATE |
Applicant: | Mylan |
Ingredient: | glatiramer acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 091646
Suppliers and Packaging for NDA: 091646
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GLATIRAMER ACETATE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 091646 | ANDA | Mylan Pharmaceuticals Inc. | 0378-6960 | 0378-6960-93 | 30 BLISTER PACK in 1 CARTON (0378-6960-93) / 1 SYRINGE in 1 BLISTER PACK (0378-6960-32) / 1 mL in 1 SYRINGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 20MG/ML | ||||
Approval Date: | Oct 3, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription